Amnioinfusion for third trimester preterm premature rupture of membranes.

Authors:
Dr Ahizechukwu C Eke, MD, MPH, FWACS
Dr Ahizechukwu C Eke, MD, MPH, FWACS
Division of Maternal Fetal Medicine & Clinical Pharmacology, Johns Hopkins University School of Medicine, 600 N Wolfe Street
Maternal Fetal Medicine
Baltimore, Maryland | United States

Cochrane Database Syst Rev 2014 Mar 30(3):CD000942. Epub 2014 Mar 30.

Department of Obstetrics and Gynaecology, East London Hospital Complex, University of the Witwatersrand, University of Fort Hare, Eastern Cape Department of Health, Frere and Cecilia Makiwane Hospitals, Private Bag X 9047, East London, Eastern Cape, South Africa, 5200.

Background: Preterm premature rupture of membranes (PPROM) is a leading cause of perinatal morbidity and mortality. Amnioinfusion aims to restore amniotic fluid volume by infusing a solution into the uterine cavity.

Objectives: The objective of this review was to assess the effects of amnioinfusion for PPROM on perinatal and maternal morbidity and mortality.

Search Methods: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (2 December 2013).

Selection Criteria: Randomised trials of amnioinfusion compared with no amnioinfusion in women with PPROM.

Data Collection And Analysis: Three review authors independently assessed trials for inclusion. Two review authors independently assessed trial quality and extracted data. Data were checked for accuracy.

Main Results: We included five trials, of moderate quality, but we only analysed data from four studies (with a total of 241 participants). One trial did not contribute any data to the review.Transcervical amnioinfusion improved fetal umbilical artery pH at delivery (mean difference 0.11; 95% confidence interval (CI) 0.08 to 0.14; one trial, 61 participants) and reduced persistent variable decelerations during labour (risk ratio (RR) 0.52; 95% CI 0.30 to 0.91; one trial, 86 participants).Transabdominal amnioinfusion was associated with a reduction in neonatal death (RR 0.30; 95% CI 0.14 to 0.66; two trials, 94 participants), neonatal sepsis (RR 0.26; 95% CI 0.11 to 0.61; one trial, 60 participants), pulmonary hypoplasia (RR 0.22; 95% CI 0.06 to 0.88; one trial, 34 participants) and puerperal sepsis (RR 0.20; 95% CI 0.05 to 0.84; one trial, 60 participants). Women in the amnioinfusion group were also less likely to deliver within seven days of membrane rupture (RR 0.18; 95% CI 0.05 to 0.70; one trial, 34 participants). These results should be treated with circumspection as the positive findings were mainly due to one trial with unclear allocation concealment.

Authors' Conclusions: These results are encouraging but are limited by the sparse data and unclear methodological robustness, therefore further evidence is required before amnioinfusion for PPROM can be recommended for routine clinical practice.

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD000942.pub3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061243PMC
March 2014
11 Reads
1 Citation

Publication Analysis

Top Keywords

trial participants
20
trial
9
amnioinfusion
9
amnioinfusion pprom
8
authors independently
8
review authors
8
premature rupture
8
independently assessed
8
rupture membranes
8
preterm premature
8
95% 005
8
participants
7
95%
7
trials
5
data
5
persistent variable
4
risk ratio
4
014 trial
4
labour risk
4
participants reduced
4

References

(Supplied by CrossRef)
The use of amnioinfusion in preterm deliveries. Preliminary results [abstract]
Gonzalez et al.
Journal of Perinatal Medicine 2001
Prophylactic intrapartum amnioinfusion in patients with preterm premature rupture of membranes
Nageotte et al.
American Journal of Obstetrics and Gynecology 1985
Transcervical intrapartum amnioinfusion for preterm premature rupture of the membranes
Puertas et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology 2007
Transabdominal amnioinfusion in preterm premature rupture of membranes
Singla et al.
International Journal of Gynecology & Obstetrics 2010
Transabdominal amnioinfusion in preterm premature rupture of membranes: a randomised controlled trial
Tranquilli et al.
BJOG: an international journal of obstetrics and gynaecology 2005
Evaluation of transabdominal amnioinfusion in the antepartum management of oligohydramnios complicating preterm pregnancies
Gowri et al.
Journal of Obstetrics and Gynaecology of India 2004
Role of amnioinfusion in the management of premature rupture of membranes at < 26 weeks gestation
Locatelli et al.
American Journal of Obstetrics and Gynecology 2000
Influence of amnioinfusion on variable or prolonged decelarations: a randomised study
Mino et al.
Acta Obstetricia et Gynecologica Scandinavica 1997
Amnioinfusion in term labor with low amniotic fluid due to rupture of membranes: a new indication
Mino et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology 1999

Similar Publications